Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014)
Bausch Health Companies' (BHC) quarterly Non Operating Investment Income came in at $293.0 million in Q4 2014, up 11620.0% quarter-over-quarter from $2.5 million in Q2 2014.
Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014) Analysis & Trends
Bausch Health Companies has disclosed Non Operating Investment Income across 5 years of filings, most recently posting $293.0 million for Q4 2014.
- Non Operating Investment Income for Q4 2014 came in at $293.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $293.0 million (down 0.85% YoY), and the FY2014 annual result was $293.0 million, up 4951.72% from the prior year.
- Non Operating Investment Income came in at $293.0 million for Q4 2014 at Bausch Health Companies, up from $2.5 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $293.0 million in Q4 2014 to a low of -$5.0 million in Q3 2010.
- The 5-year median for Non Operating Investment Income is $922500.0 (2011), against an average of $22.9 million.
- Across the five-year window, Non Operating Investment Income tumbled 100.17% in 2012 and soared 11242.86% in 2013, its largest moves.
- Bausch Health Companies' Non Operating Investment Income stood at -$5.0 million in 2010, then jumped by 99.78% to -$11000.0 in 2011, then soared by 790.91% to $76000.0 in 2012, then jumped by 5031.58% to $3.9 million in 2013, then soared by 7412.82% to $293.0 million in 2014.
- The last three Non Operating Investment Income figures came in at $293.0 million (Q4 2014), $2.5 million (Q2 2014), and $3.9 million (Q2 2013), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Bausch Health Companies | 1.92 Bn | 1.58 Bn | 2.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 293.00 Mn |
| Dec 31, 2014 | 293.00 Mn |
| Jun 30, 2014 | 2.50 Mn |
| Jun 30, 2014 | 2.50 Mn |
| Jun 30, 2013 | 3.90 Mn |
| Jun 30, 2013 | 3.90 Mn |
| Mar 31, 2013 | 1.86 Mn |
| Mar 31, 2013 | 1.86 Mn |
| Dec 31, 2012 | 76,000.00 |
| Dec 31, 2012 | 76,000.00 |
| Jun 30, 2012 | -35,000.00 |
| Jun 30, 2012 | -35,000.00 |
| Mar 31, 2012 | 2.06 Mn |
| Mar 31, 2012 | 2.06 Mn |
| Dec 31, 2011 | -11,000.00 |
| Dec 31, 2011 | -11,000.00 |
| Sep 30, 2011 | -140,000.00 |
| Sep 30, 2011 | -140,000.00 |
| Jun 30, 2011 | 21.16 Mn |
| Jun 30, 2011 | 21.16 Mn |